🔴 Intravenous Infusions is trading 9.38% down today after continued profit-taking

Intravenous Infusions is trading 9.38% down at GHS 0.58 after continued profit-taking following a speculative rally.

• Recent selling followed the GHS 0.86 level reached on July 30.
• First-half revenue fell 39%, despite improved margins and a return to profitability.
• Broader markets were broadly steady; no new August 10, 2026 company announcement or major market catalyst was identified.